{"id":"W2339149872","doi":"10.1200/jco.2015.64.3171","title":"Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer: TEXT and SOFT Trials","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":182,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada); Boehringer Ingelheim (Canada)","funders":"National Cancer Institute; Cancer Research UK","keywords":"Exemestane; Medicine; Tamoxifen; Breast cancer; Oncology; Internal medicine; Population; Gynecology; Estrogen receptor; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001331063,0.0002691175,0.001769953,0.00006292741,0.0000906651,0.000009774271,0.0001939041,0.0002239774,0.0001028054],"category_scores_gemma":[0.0009468802,0.0001473511,0.0002288185,0.00005495608,0.000564303,0.00002942071,0.00009760611,0.0001787917,0.000001065965],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001304326,"about_ca_system_score_gemma":0.0004096138,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001140584,"about_ca_topic_score_gemma":0.0001033177,"domain_scores_codex":[0.9969172,0.0004222774,0.001738022,0.0003426911,0.000211938,0.0003678475],"domain_scores_gemma":[0.9945484,0.001715197,0.002465339,0.0001524379,0.0008863548,0.0002323051],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.07177687,0.001430429,0.09591512,0.00005355651,0.008323931,0.00001475967,0.0007458528,0.000001944824,0.3654054,0.0001646669,0.003113887,0.4530536],"study_design_scores_gemma":[0.01974136,0.02966051,0.923683,0.0001262692,0.0003251892,0.0000654262,0.0001618523,2.371012e-7,0.01930701,0.0003833167,0.00628676,0.0002590294],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911755,0.001749406,0.0002589392,0.005050148,0.0002900632,0.000473352,0.0009520612,0.000004863306,0.00004560546],"genre_scores_gemma":[0.991899,0.00454445,0.001806722,0.0002135219,0.001228555,0.0001122905,0.000006710407,0.00003237462,0.0001563799],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8277679,"threshold_uncertainty_score":0.6008805,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05678427435732385,"score_gpt":0.3879864615385772,"score_spread":0.3312021871812534,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}